Holly Springs, NC, United States of America

Joseph Balleydier

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Novartis Ag. Active years: 2024.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Joseph Balleydier: Innovator in Viral Vector Technology

Introduction

Joseph Balleydier is a notable inventor based in Holly Springs, NC (US). He has made significant contributions to the field of viral vector technology, which is crucial for various applications in medicine and biotechnology. His innovative work has led to the development of methods that enhance the production and purification of viral particles.

Latest Patents

Joseph Balleydier holds a patent titled "Means and method for producing and purifying viral vectors." This patent encompasses methods for preparing and purifying viral particles, along with compositions and uses that incorporate these advancements. He has 1 patent to his name, showcasing his expertise in this specialized area.

Career Highlights

Balleydier is currently employed at Novartis AG, a leading global healthcare company. His role at Novartis allows him to work on cutting-edge research and development projects that aim to improve therapeutic options for patients. His contributions to the field have been recognized within the industry, marking him as a key player in viral vector research.

Collaborations

Joseph collaborates with James Michael Hatfield, who is also involved in similar research endeavors. Their partnership exemplifies the collaborative spirit often found in scientific research, where shared knowledge and expertise can lead to groundbreaking innovations.

Conclusion

Joseph Balleydier's work in viral vector technology represents a significant advancement in the field. His patent and ongoing contributions at Novartis AG highlight his commitment to improving medical solutions through innovative research.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…